Physica Kinematic Retaining Knee System
DeviceModular total knee prosthesis with a Kinematic Retaining mechanism and posterior cruciate ligament (PCL) preservation
NCT Number: NCT03048201
The primary objective of this study is to obtain long-term implant survivorship (out to 10 years) and to assess clinical, patient-reported outcome measures, and radiographic data for the commercially available Physica system. For ancillary arm, from baseline to 5-year follow-up.
Interested in participating?
Request Info22 year and older
All sexes
Interventional
Not applicable
Eisenhower Desert Orthopedics Center - Harry and Diane Rinker Bldg, Rancho Mirage, California, United States
This is a post-market registry study; the study device is FDA cleared and used according to the intended use.
This is a multi-centre, prospective, non-randomized study.
Subjects will be implanted with one of the following configurations of the Physica system: Physica KR (Kinematic Retaining), Physica CR (Cruciate Retaining) or Physica PS (Posterior Stabilized). The assignment of any patient involved in the study is determined by the aetiology preoperatively evaluated by the Investigator and falls within current practice. The decision to use a specific prosthesis design is decided by the Investigators independently and clearly separated from the decision to include the patient in the study.
For the ancillary subgroup, investigators currently contributing to the primary patient group can also enroll additional patients to the ancillary subgroup. 3 existing sites and 2 additional sites are planned to be added to contribute to the additional 300 patients to be enrolled. These patients will follow the same study schedules as the main study, but follow-up is only up to 5 years.
Baseline measurements (pre-operative clinical analysis and radiographic analysis at 6-week FU) will serve as internal control term during the assessment of post-surgery data out to 10 years.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
including knee osteoarthritis, post-traumatic knee arthritis; or patients who are suffering from inflammatory arthritis; or patients that need correction of a functional deformity
Exclusion criteria
Modular total knee prosthesis with a Kinematic Retaining mechanism and posterior cruciate ligament (PCL) preservation
Total knee prosthesis with posterior cruciate ligament (PCL) preservation
Total knee prosthesis that sacrifices the posterior cruciate ligament (PCL) and replaces the functionality of the PCL with a post-cam mechanism.
Total knee prosthesis with posterior cruciate ligament (PCL) preservation
Time frame: 10 years
The primary endpoint is the definition of the implant survivorship of the study device to 10 years after the total knee replacement surgery.
Time frame: 10 years
Clinical performance assessment measured by overall pain and functionality from baseline to 10-year follow-up
Time frame: 10 years
Patient-Reported Outcome Measures (PROMs) including patient satisfaction achievement from baseline to 10-year follow-up
Time frame: 10 years
Contact information is provided by the study sponsor or research team.
Limacorporate S.p.a
Industry
Post-market Registry Study on the Physica System Total Knee Replacement
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05787821
Arthritis, Arthritis, Rheumatoid
Parker, Colorado, United States
View Trial DetailsNCT04910048
Arthritis, Arthritis, Rheumatoid
Little Rock, Arkansas, United States
View Trial DetailsNCT04247672
Arthritis, Arthritis, Rheumatoid
Hoofddorp, North Holland, Netherlands
View Trial DetailsNCT06514443
Ankylosis, Arthritis
View Trial Details